Results overview: Found 1 records in 0.02 seconds.
Articles, 1 records found
Articles 1 records found  
1.
15 p, 7.1 MB Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation / Fiorentino, Francesco Paolo (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Tokgün, Elvan (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Solé-Sánchez, Sònia (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Giampaolo, Sabrina (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Tokgün, Onur (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Jauset González, Toni (Vall d'Hebron Institut d'Oncologia) ; Kohno, Takashi (National Cancer Center Research Institute (Tòquio, Japó)) ; Perucho, Manuel (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Soucek, Laura (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Yokota, Jun (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer)
Small cell lung cancer (SCLC) is the most aggressive type of lung cancer with high mortality. One of the MYC family genes, MYC, MYCL or MYCN, is amplified in ~20% of the SCLCs; therefore, MYC proteins are potential therapeutic targets in SCLC patients. [...]
2016 - 10.18632/oncotarget.8826
Oncotarget, Vol. 7, Num. 21 (May 2016) , p. 31014-31028  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.